Franklin Resources’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Franklin Resources’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-580,917	Closed	-$70.3M	–	2793
2023 Q1	$70.3M	Buy	580,917 +12,650	+2%	+$1.46M	0.04%	442
2022 Q4	$65.2M	Sell	568,267 -234,251	-29%	-$25.8M	0.03%	460
2022 Q3	$81.2M	Buy	802,518 +1,333	+0.2%	+$141K	0.04%	414
2022 Q2	$81.3M	Buy	801,185 +60,470	+8%	+$6.59M	0.04%	431
2022 Q1	$86.2M	Buy	740,715 +131,380	+22%	+$15.2M	0.03%	465
2021 Q4	$69.9M	Buy	+609,335	New	+$69.5M	0.03%	548
2020 Q4	–	Sell	-362,900	Closed	-$40.6M	–	1965
2020 Q3	$40.6M	Hold	362,900	–	–	0.02%	610
2020 Q2	$40.7M	Buy	+362,900	New	+$38.9M	0.02%	586

Other funds holding BSX.PRA

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Franklin Resources's BSX.PRA Position: Q2 2023 in Review

Franklin Resources sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 580,917 shares — an estimated $70.3M sold.

Franklin Resources first reported a position in BSX.PRA in Q2 2020 and held it in 8 quarters. The position peaked at $86.2M in Q1 2022. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

Franklin Resources reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
Franklin Resources sold 580,917 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $70.3M.
Franklin Resources first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 8 quarters.
Franklin Resources's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $86.2M in Q1 2022.
1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on Franklin Resources's 13F filing for Q2 2023, filed 11 Aug 2023.